The gut microbiota, bacterial metabolites and colorectal cancer

Nature Reviews Microbiology

Volumn 12, Issue 10, 2014, Pages 661-672

  Louis, Petra ^a   Hold, Georgina L ^b   Flint, Harry J ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HYDROGEN SULFIDE; PLANT MEDICINAL PRODUCT; SHORT CHAIN FATTY ACID; XENOBIOTIC AGENT;

BILE ACID METABOLISM; BIOTRANSFORMATION; CANCER GROWTH; COLORECTAL CANCER; DIET; FERMENTATION; HOST CELL; HUMAN; INFLAMMATION; INTESTINE; INTESTINE FLORA; METABOLITE; MICROBIAL METABOLISM; MICROFLORA; NONHUMAN; PRIORITY JOURNAL; REVIEW; BACTERIUM; COLORECTAL TUMOR; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; METABOLISM; METHODOLOGY; MICROBIOLOGY;

BACTERIA (MICROORGANISMS);

BACTERIA; COLORECTAL NEOPLASMS; DIET; GASTROINTESTINAL TRACT; HUMANS;

EID: 84908608590     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro3344     Document Type: Review

References (141)

1. Jemal, A. et al. Global cancer statistics. CA Cancer J. Clin. 61, 69-90 (2011).
2. Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759-767 (1990).
3. Rabeneck, L., Davila, J. A. & El-Serag, H. B. Is there a true 'shift' to the right colon in the incidence of colorectal cancer? Am. J. Gastroenterol. 98, 1400-1409 (2003).
4. Gill, C. I. R. & Rowland, I. R. Diet and cancer: assessing the risk. Br. J. Nutr. 88, S73-S87 (2002).
5. Burn, J. et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 378, 2081-2087 (2011).
6. World Cancer Research Fund and American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. (AICR, 2007).
7. Jess, T., Gamborg, M., Matzen, P., Munkholm, P. & Srensen, T. I. A. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am. J. Gastroenterol. 100, 2724-2729 (2005).
8. Danese, S., Malesci, A. & Vetrano, S. Colitis-associated cancer: the dark side of inflammatory bowel disease. Gut 60, 1609-1610 (2011).
9. Schwabe, R. F. & Jobin, C. The microbiome and cancer. Nature Rev. Cancer 13, 800-812 (2013).
10. Kostic, A. D. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207-215 (2013).
11. Tjalsma, H., Boleij, A., Marchesi, J. R. & Dutilh, B. E. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nature Rev. Microbiol. 10, 575-582 (2012).
12. Elinav, E. et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nature Rev. Cancer 13, 759-771 (2013).
13. Sears, C. L. & Garrett, W. S. Microbes, microbiota and colon cancer. Cell Host Microbe 15, 317-328 (2014).
14. Flint, H. J., Scott, K. P., Louis, P. & Duncan, S. H. The role of the gut microbiota in nutrition and health. Nature Rev. Gastroenterol. Hepatol. 9, 577-589 (2012).
15. Eckburg, P. B. et al. Microbiology: diversity of the human intestinal microbial flora. Science 308, 1635-1638 (2005).
16. Walker, A. W. et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 5, 220-230 (2011).
17. David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-563 (2014).
18. Flint, H. J., Scott, K. P., Duncan, S. H., Louis, P. & Forano, E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3, 289-306 (2012).
19. Salonen, A. et al. Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME J. http:// dx.doi.org/10.1038/ismej.2014.63 (2014).
20. Duncan, S. H. et al. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl. Environ. Microbiol. 73, 1073-1078 (2007).
21. Wu, G. D. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105-108 (2011).
22. De Filippo, C. et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl Acad. Sci. USA 107, 14691-14696 (2010).
23. Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541-546 (2013).
24. Cotillard, A. et al. Dietary intervention impact on gut microbial gene richness. Nature 500, 585-588 (2013).
25. Aune, D. et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 343, 1082 (2011).
26. Chen, H. -M. et al. Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am. J. Clin. Nutr. 97, 1044-1052 (2013).
27. Ou, J. et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am. J. Clin. Nutr. 98, 111-120 (2013).
28. Marcobal, A. et al. A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice. ISME J. 7, 1933-1943 (2013).
29. Macfarlane, G. T. & Gibson, G. R. in Gastrointestinal Microbiology Vol. 1 (eds Mackie, R. I. & White, B. A.) 269-318 (Chapman and Hall, 1997).
30. Sieber, J. R., McInerney, M. J. & Gunsalus, R. P. Genomic insights into syntrophy: the paradigm for anaerobic metabolic cooperation. Annu. Rev. Microbiol. 66, 429-452 (2012).
31. Baughn, A. D. & Malamy, M. H. The strict anaerobe Bacteroides fragilis grows in and benefits from nanomolar concentrations of oxygen. Nature 427, 441-444 (2004).
32. Khan, M. T. et al. The gut anaerobe Faecalibacterium prausnitzii uses an extracellular electron shuttle to grow at oxic-anoxic interphases. ISME J. 6, 1578-1585 (2012).
33. Circu, M. L. & Aw, T. Y. Intestinal redox biology and oxidative stress. Semin. Cell Dev. Biol. 23, 729-737 (2012).
34. Nava, G. M., Carbonero, F., Croix, J. A., Greenberg, E. & Gaskins, H. R. Abundance and diversity of mucosaassociated hydrogenotrophic microbes in the healthy human colon. ISME J. 6, 57-70 (2012).
35. Carbonero, F., Benefiel, A. C. & Gaskins, H. R. Contributions of the microbial hydrogen economy to colonic homeostasis. Nature Rev. Gastroenterol. Hepatol. 9, 504-518 (2012).
36. Lewis, S. & Cochrane, S. Alteration of sulfate and hydrogen metabolism in the human colon by changing intestinal transit rate. Am. J. Gastroenterol. 102, 624-633 (2007).
37. Miller, T. L. & Wolin, M. J. Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Appl. Environ. Microbiol. 62, 1589-1592 (1996).
38. Belenguer, A. et al. Impact of pH on lactate formation and utilization by human fecal microbial communities. Appl. Environ. Microbiol. 73, 6526-6533 (2007).
39. Walker, A. W., Duncan, S. H., McWilliam Leitch, E. C., Child, M. W. & Flint, H. J. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl. Environ. Microbiol. 71, 3692-3700 (2005).
40. Reichardt, N. et al. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 8, 1323-1335 (2014).
41. Louis, P. et al. Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J. Bacteriol. 186, 2099-2106 (2004).
42. Louis, P., Young, P., Holtrop, G. & Flint, H. J. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ. Microbiol. 12, 304-314 (2010).
43. Louis, P. & Flint, H. J. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 294, 1-8 (2009).
44. Barcenilla, A. et al. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl. Environ. Microbiol. 66, 1654-1661 (2000).
45. Sleeth, M. L., Thompson, E. L., Ford, H. E., Zac-Varghese, S. E. K. & Frost, G. Free fatty acid receptor 2 and nutrient sensing: a proposed role for fibre, fermentable carbohydrates and short-chain fatty acids in appetite regulation. Nutr. Res. Rev. 23, 135-145 (2010).
46. Fung, K. Y. C., Cosgrove, L., Lockett, T., Head, R. & Topping, D. L. A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. Br. J. Nutr. 108, 820-831 (2012).
47. Wilson, A. J. et al. Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction. Cancer Res. 70, 609-620 (2010).
48. Hamer, H. M. et al. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27, 104-119 (2008).
49. Chang, P. V., Hao, L., Offermanns, S. & Medzhitov, R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl Acad. Sci. USA 111, 2247-2252 (2014).
50. Smith, P. M. et al. The microbial metabolites, shortchain fatty acids, regulate colonic T reg cell homeostasis. Science 341, 569-573 (2013).
51. Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446-450 (2013).
52. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341 (2011).
53. Geuking, M. et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 34, 794-806 (2011).
54. Round, J. L. & Mazmanian, S. K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl Acad. Sci. USA 107, 12204-12209 (2010).
55. O'Mahony, C. et al. Commensal-induced regulatory T cells mediate protection against pathogenstimulated NF-κB activation. PLoS Pathog. 4, e1000112 (2008).
56. Chung, H. et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 149, 1578-1593 (2012).
57. Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451-455 (2013).
58. Latham, T. et al. Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression. Nucleic Acids Res. 40, 4794-4803 (2012).
59. Ganapathy, V., Thangaraju, M., Prasad, P. D., Martin, P. M. & Singh, N. Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr. Opin. Pharmacol. 13, 869-874 (2013).
60. Frank, H. et al. Lactaturia and loss of sodium-dependent lactate uptake in the colon of SLC5A8-deficient mice. J. Biol. Chem. 283, 24729-24737 (2008).
61. Brown, A. J. et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278, 11312-11319 (2003).
62. Singh, N. et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40, 128-139 (2014).
63. Thangaraju, M. et al. GPFM 09A is a G-proteincoupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 69, 2826-2832 (2009).
64. Maslowski, K. M. et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282-1286 (2009).
65. Buda, A. et al. Butyrate downregulates a2β1 integrin: a possible role in the induction of apoptosis in colorectal cancer cell lines. Gut 52, 729-734 (2003).
66. Clarke, J. M., Topping, D. L., Bird, A. R., Young, G. P. & Cobiac, L. Effects of high-amylose maize starch and butyrylated high-amylose maize starch on azoxymethane-induced intestinal cancer in rats. Carcinogenesis 29, 2190-2194 (2008).
67. Nepelska, M. et al. Butyrate produced by commensal bacteria potentiates phorbol esters induced AP-1 response in human intestinal epithelial cells. PLoS ONE 7, e52869 (2012).
68. Belcheva, A. et al. Gut microbial metabolism drives transformation of Msh2-deficient colon epithelial cells. Cell 158, 288-299 (2014).
69. Ramos, S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol. Nutr. Food Res. 52, 507-526 (2008).
70. Herr, I. & Büchler, M. W. Dietary constituents of broccoli and other cruciferous vegetables: implications for prevention and therapy of cancer. Cancer Treat. Rev. 36, 377-383 (2010).
71. Chiva-Blanch, G. & Visioli, F. Polyphenols and health: moving beyond antioxidants. J. Berry Res. 2, 63-71 (2012).
72. Bennett, L. L., Rojas, S. & Seefeldt, T. Role of antioxidants in the prevention of cancer. J. Exp. Clin. Med. 4, 215-222 (2012).
73. Russell, W. & Duthie, G. Plant secondary metabolites and gut health: the case for phenolic acids. Proc. Nutr. Soc. 70, 389-396 (2011).
74. Russell, W. R., Hoyles, L., Flint, H. J. & Dumas, M. -E. Colonic bacterial metabolites and human health. Curr. Opin. Microbiol. 16, 246-254 (2013).
75. Cardona, F., Andrés-Lacueva, C., Tulipani, S., Tinahones, F. J. & Queipo-Ortuo, M. I. Benefits of polyphenols on gut microbiota and implications in human health. J. Nutr. Biochem. 24, 1415-1422 (2013).
76. Russell, W. R., Labat, A., Scobbie, L. & Duncan, S. H. Availability of blueberry phenolics for microbial metabolism in the colon and the potential inflammatory implications. Mol. Nutr. Food Res. 51, 726-731 (2007).
77. Larrosa, M. et al. Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models. Mol. Nutr. Food Res. 53, 1044-1054 (2009).
78. Etxeberria, U. et al. Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J. Agr. Food Chem. 61, 9517-9533 (2013).
79. Kim, D. -H. & Jin, Y. -H. Intestinal bacterial β-glucuronidase activity of patients with colon cancer. Arch. Pharm. Res. 24, 564-567 (2001).
80. Humblot, C. et al. β-glucuronidase in human intestinal microbiota is necessary for the colonic genotoxicity of the food-borne carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline in rats. Carcinogenesis 28, 2419-2425 (2007).
81. McIntosh, F. M. et al. Phylogenetic distribution of genes encoding β-glucuronidase activity in human colonic bacteria and the impact of diet on faecal glycosidase activities. Environ. Microbiol. 14, 1876-1887 (2012).
82. Wallace, B. D. et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330, 831-835 (2010).
83. Russell, W. R. et al. High-protein, reducedcarbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am. J. Clin. Nutr. 93, 1062-1072 (2011).
84. Windey, K., de Preter, V. & Verbeke, K. Relevance of protein fermentation to gut health. Mol. Nutr. Food Res. 56, 184-196 (2012).
85. Russell, W. R. et al. Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein. Mol. Nutr. Food Res. 57, 523-535 (2013).
86. Loh, Y. H. et al. N-nitroso compounds and cancer incidence: The European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study. Am. J. Clin. Nutr. 93, 1053-1061 (2011).
87. Hughes, R. & Rowland, I. R. Metabolic activities of the gut microflora in relation to cancer. Microb. Ecol. Health Dis. 12, 179-185 (2000).
88. Di Martino, M. L. et al. Polyamines: emerging players in bacteria-host interactions. Int. J. Med. Microbiol. 303, 484-491 (2013).
89. Pegg, A. E. Toxicity of polyamines and their metabolic products. Chem. Res. Toxicol. 26, 1782-1800 (2013).
90. Hanfrey, C. C. et al. Alternative spermidine biosynthetic route is critical for growth of Campylobacter jejuni and is the dominant polyamine pathway in human gut microbiota. J. Biol. Chem. 286, 43301-43312 (2011).
91. Toden, S., Bird, A. R., Topping, D. L. & Conlon, M. A. Resistant starch prevents colonic DNA damage induced by high dietary cooked red meat or casein in rats. Cancer Biol. Ther. 5, 267-272 (2006).
92. Windey, K. et al. Modulation of protein fermentation does not affect fecal water toxicity: a randomized cross-over study in healthy subjects. PLoS ONE 7, e52387 (2012).
93. Kuhnle, G. G. C. et al. Diet-induced endogenous formation of nitroso compounds in the GI tract. Free Radic. Bio. Med. 43, 1040-1047 (2007).
94. Magee, E. A., Richardson, C. J., Hughes, R. & Cummings, J. H. Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans. Am. J. Clin. Nutr. 72, 1488-1494 (2000).
95. Marquet, P., Duncan, S. H., Chassard, C., Bernalier-Donadille, A. & Flint, H. J. Lactate has the potential to promote hydrogen sulphide formation in the human colon. FEMS Microbiol. Lett. 299, 128-134 (2009).
96. Roediger, W. E. W., Moore, J. & Babidge, W. Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Dig. Dis. Sci. 42, 1571-1579 (1997).
97. Attene-Ramos, M. S. et al. DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 int cells. Environ. Mol. Mutag. 51, 304-314 (2010).
98. Attene-Ramos, M. S., Wagner, E. D., Gaskins, H. R. & Plewa, M. J. Hydrogen sulfide induces direct radicalassociated DNA damage. Mol. Cancer Res. 5, 455-459 (2007).
99. Barrasa, J. I., Olmo, N., Lizarbe, M. A. & Turnay, J. Bile acids in the colon, from healthy to cytotoxic molecules. Toxicol. In Vitro 27, 964-977 (2013).
100. Bernstein, H., Bernstein, C., Payne, C. M. & Dvorak, K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J. Gastroentero. 15, 3329-3340 (2009).
101. Ou, J., DeLany, J. P., Zhang, M., Sharma, S. & O'Keefe, S. J. D. Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations. Nutr. Cancer 64, 34-40 (2012).
102. Yoshimoto, S. et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97-101 (2013).
103. Islam, K. B. M. S. et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 141, 1773-1781 (2011).
104. Ridlon, J. M., Kang, D. -J. & Hylemon, P. B. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47, 241-259 (2006).
105. Jones, B. V., Begley, M., Hill, C., Gahan, C. G. M. & Marchesi, J. R. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc. Natl Acad. Sci. USA 105, 13580-13585 (2008).
106. Ridlon, J. M. & Hylemon, P. B. Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7a-dehydroxylating intestinal bacterium. J. Lipid Res. 53, 66-76 (2012).
107. Májer, F. et al. New highly toxic bile acids derived from deoxycholic acid, chenodeoxycholic acid and lithocholic acid. Bioorgan. Med. Chem. 22, 256-268 (2014).
108. Lee, J. Y. et al. Contribution of the 7β-hydroxysteroid dehydrogenase from Ruminococcus gnavus N53 to ursodeoxycholic acid formation in the human colon. J. Lipid Res. 54, 3062-3069 (2013).
109. Devkota, S. et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10 -/-mice. Nature 486, 104-108 (2012).
110. Homann, N. Alcohol and upper gastrointestinal tract cancer: the role of local acetaldehyde production. Addict. Biol. 6, 309-323 (2001).
111. Hooper, S. J., Wilson, M. J. & Crean, S. J. Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck 31, 1228-1239 (2009).
112. Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883-899 (2010).
113. Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331, 1565-1570 (2011).
114. Arthur, J. C. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120-123 (2012).
115. Dove, W. F. et al. Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res. 57, 812-814 (1997).
116. Fukata, M. et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 133, 1869-1881 (2007).
117. Kobayashi, K. S. et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731-734 (2005).
118. Neal, M. D. et al. Toll-like receptor 4 is expressed on intestinal stem cells and regulates their proliferation and apoptosis via the p53 up-regulated modulator of apoptosis. J. Biol. Chem. 287, 37296-37308 (2012).
119. Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nature Med. 15, 1016-1022 (2009).
120. Sears, C. L. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin. Microbiol. Rev. 22, 349-369 (2009).
121. Goodwin, A. C. et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc. Natl Acad. Sci. USA 108, 15354-15359 (2011).
122. Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292-298 (2012).
123. Warren, R. L. et al. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome 1, 16 (2013).
124. Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195-206 (2013).
125. Cuevas-Ramos, G. et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Natl Acad. Sci. USA 107, 11537-11542 (2010).
126. Nougayrède, J. -P. et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313, 848-851 (2006).
127. Inaba, Y. et al. Expression of the antimicrobial peptide α-defensin/cryptdins in intestinal crypts decreases at the initial phase of intestinal inflammation in a model of inflammatory bowel disease, IL-10-deficient mice. Inflamm. Bowel Dis. 16, 1488-1495 (2010).
128. Schwerbrock, N. M. J. et al. Interleukin 10-deficient mice exhibit defective colonic Muc2 synthesis before and after induction of colitis by commensal bacteria. Inflamm. Bowel Dis. 10, 811-823 (2004).
129. Secher, T., Samba-Louaka, A., Oswald, E. & Nougayrède, J. -P. Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells. PLoS ONE 8, e77157 (2013).
130. Mukhopadhya, I., Hansen, R., El-Omar, E. M. & Hold, G. L. IBD - what role do Proteobacteria play? Nature Rev. Gastroenterol. Hepatol. 9, 219-230 (2012).
131. Grivennikov, S. I. et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491, 254-258 (2012).
132. Vogelstein, B. et al. Cancer genome landscapes. Science 340, 1546-1558 (2013).
133. McLean, M. H. et al. The inflammatory microenvironment in colorectal neoplasia. PLoS ONE 6, e15366 (2011).
134. Lewis, S. J. & Heaton, K. W. Increasing butyrate concentration in the distal colon by accelerating intestinal transit. Gut 41, 245-251 (1997).
135. Stephen, A. M., Wiggins, H. S. & Cummings, J. H. Effect of changing transit time on colonic microbial metabolism in man. Gut 28, 601-609 (1987).
136. Wichmann, A. et al. Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host Microbe 14, 582-590 (2013).
137. McOrist, A. L. et al. Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch. J. Nutr. 141, 883-889 (2011).
138. Shen, X. J. et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 1, 138-147 (2010).
139. Sanapareddy, N. et al. Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J. 6, 1858-1868 (2012).
140. Wang, T. et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 6, 320-329 (2012).
141. Zackular, J. P. et al. The gut microbiome modulates colon tumorigenesis. mBio 4, e00692-13 (2013).